Authors:
Vandenbroucke, JP
van der Meer, FJM
Helmerhorst, FM
Rosendaal, FR
Citation: Jp. Vandenbroucke et al., Family history and risk of venous thromboembolism with oral contraception - Family history is important tool, BR MED J, 323(7315), 2001, pp. 752-752
Authors:
Odink, AE
van Asperen, CJ
Vandenbroucke, JP
Cleton-Jansen, AM
Hogendoom, PCW
Citation: Ae. Odink et al., An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait, J PATHOLOGY, 193(2), 2001, pp. 190-192
Authors:
Lensen, R
Bertina, RM
Vandenbroucke, JP
Rosendaal, FR
Citation: R. Lensen et al., High factor VIII levels contribute to the thrombotic risk in families withfactor V Leiden, BR J HAEM, 114(2), 2001, pp. 380-386
Authors:
Bloemenkamp, KWM
Helmerhorst, FM
Rosendaal, FR
Vandenbroucke, JP
Citation: Kwm. Bloemenkamp et al., Lack of objectivity in the debate concerning third-generation oral contraceptives and venous thrombosis - In reply, ARCH IN MED, 161(3), 2001, pp. 484-485
Citation: Jp. Vandenbroucke et Ajm. De Craen, Alternative medicine: A "mirror image" for scientific reasoning in conventional medicine, ANN INT MED, 135(7), 2001, pp. 507-513
Authors:
Vandenbroucke, JP
Helmerhorst, FM
Rosendaal, FR
Citation: Jp. Vandenbroucke et al., Competing interests and controversy about third generation oral contraceptives - BMJ readers should know whose words they read, BR MED J, 320(7231), 2000, pp. 381-382
Authors:
Vandenbroucke, JP
Bloemenkamp, KWM
Rosendaal, FR
Helmerhorst, FM
Citation: Jp. Vandenbroucke et al., Incidence of venous thromboembolism in users of combined oral contraceptives - Risk is particularly high with first use of oral contraceptives, BR MED J, 320(7226), 2000, pp. 57-57
Citation: Bm. Psaty et al., Association of the alpha-adducin polymorphism with blood pressure and riskof myocardial infarction, J HUM HYPER, 14(2), 2000, pp. 95-97
Authors:
Lensen, RPM
Bertina, RM
de Ronde, H
Vandenbroucke, JP
Rosendaal, FR
Citation: Rpm. Lensen et al., Venous thrombotic risk in family members of unselected individuals with factor V Leiden, THROMB HAEM, 83(6), 2000, pp. 817-821
Authors:
Csizmadia, CGDS
Mearin, ML
Oren, A
Krombout, A
Crusius, JBA
von Blomberg, BME
Pena, AS
Wiggers, MNL
Vandenbroucke, JP
Citation: Cgds. Csizmadia et al., Accuracy and cost-effectiveness of a new strategy to screen for celiac disease in children with Down syndrome, J PEDIAT, 137(6), 2000, pp. 756-761
Authors:
Janssen, HLA
Meinardi, JR
Vleggaar, FP
van Uum, SHM
Haagsma, EB
van der Meer, FJM
van Hattum, J
Chamuleau, RAFM
Adang, RP
Vandenbroucke, JP
van Hoek, B
Rosendaal, FR
Citation: Hla. Janssen et al., Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study, BLOOD, 96(7), 2000, pp. 2364-2368
Authors:
Bloemenkamp, KWM
Rosendaal, FR
Helmerhorst, FM
Vandenbroucke, JP
Citation: Kwm. Bloemenkamp et al., Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects, ARCH IN MED, 160(1), 2000, pp. 49-52
Authors:
Sont, JK
Willems, LNA
Bel, EH
van Krieken, JHJM
Vandenbroucke, JP
Sterk, PJ
Citation: Jk. Sont et al., Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment, AM J R CRIT, 159(4), 1999, pp. 1043-1051
Authors:
Hille, ETM
Siesling, S
Vegter-van der Vlis, M
Vandenbroucke, JP
Roos, RAC
Rosendaal, FR
Citation: Etm. Hille et al., Two centuries of mortality in ten large families with Huntington disease: A rising impact of gene carriership, EPIDEMIOLOG, 10(6), 1999, pp. 706-710